Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Long-Term Debt Issuances (2016 - 2023)

Historic Long-Term Debt Issuances for Amphastar Pharmaceuticals (AMPH) over the last 6 years, with Q3 2023 value amounting to $345.0 million.

  • Amphastar Pharmaceuticals' Long-Term Debt Issuances changed N/A to $345.0 million in Q3 2023 from the same period last year, while for Dec 2023 it was $348.2 million, marking a year-over-year change of. This contributed to the annual value of $845.0 million for FY2023, which is N/A changed from last year.
  • Amphastar Pharmaceuticals' Long-Term Debt Issuances amounted to $345.0 million in Q3 2023.
  • Amphastar Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $345.0 million during Q3 2023, with a 5-year trough of $3.1 million in Q1 2020.